Brief: Odonate Therapeutics Reports Quarterly Loss Per Share $0.99
28/04/2020 13:37
April 28 (Reuters) - Odonate Therapeutics Inc ODT.O :
* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE
MONTHS ENDED MARCH 31, 2020
* QUARTERLY LOSS PER SHARE $0.99
* AS OF MARCH 31, 2020, ODONATE HAD $153.1 MILLION IN CASH,
COMPARED TO $180.5 MILLION AS OF DECEMBER 31, 2019
* CONTINUE TO EXPECT TO REPORT TOP-LINE RESULTS FROM
CONTESSA, AS
A POTENTIAL TREATMENT FOR BREAST CANCER, IN Q3
Source text for Eikon: ID:nBwb8NqCsa
Further company coverage: ODT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Odonate
See all newsBrief: Odonate Announces Expected Delisting Of Its Stock
Brief: Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Odonate Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview